LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 63 filers reported holding LOGICBIO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 1,231 | +0.4% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 1,226 | +0.8% | 0.00% | – |
| Q1 2022 | $1,000 | -66.7% | 1,216 | +0.2% | 0.00% | – |
| Q4 2021 | $3,000 | -50.0% | 1,213 | 0.0% | 0.00% | – |
| Q3 2021 | $6,000 | +200.0% | 1,213 | +101.8% | 0.00% | – |
| Q2 2021 | $2,000 | -99.7% | 601 | -99.4% | 0.00% | – |
| Q1 2021 | $739,000 | +435.5% | 101,384 | +460.6% | 0.00% | – |
| Q4 2020 | $138,000 | +23.2% | 18,084 | +46.0% | 0.00% | – |
| Q3 2020 | $112,000 | -14.5% | 12,388 | -20.3% | 0.00% | – |
| Q2 2020 | $131,000 | +178.7% | 15,543 | +61.8% | 0.00% | – |
| Q1 2020 | $47,000 | -34.7% | 9,609 | -3.7% | 0.00% | – |
| Q4 2019 | $72,000 | -32.7% | 9,983 | +0.1% | 0.00% | – |
| Q3 2019 | $107,000 | -15.1% | 9,972 | +2.6% | 0.00% | – |
| Q2 2019 | $126,000 | +34.0% | 9,719 | +2.4% | 0.00% | – |
| Q1 2019 | $94,000 | -3.1% | 9,489 | +0.9% | 0.00% | – |
| Q4 2018 | $97,000 | – | 9,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 500,000 | $2,470,000 | 0.65% |
| Orbimed Advisors | 6,466,783 | $31,946,000 | 0.54% |
| SAMLYN CAPITAL, LLC | 798,566 | $3,945,000 | 0.10% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 915,355 | $4,522,000 | 0.01% |
| IHT Wealth Management, LLC | 11,660 | $58,000 | 0.01% |
| FIDUCIARY TRUST CO | 37,998 | $188,000 | 0.01% |
| FRANKLIN RESOURCES INC | 700,000 | $3,458,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 13,700 | $68,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 2,249 | $11,000 | 0.00% |
| MANCHESTER FINANCIAL INC | 200 | $1,000 | 0.00% |